On this page
What is Liver cirrhosis?
Liver cirrhosis is a condition in which the liver progressively deteriorates and loses function due to chronic, irreversible damage. Scar tissue gradually replaces healthy liver tissue, partially obstructing blood flow to the liver. This scarring naturally impairs the organ’s normal functions, including its ability to:
- fight infections,
- clear bacteria and toxins from the blood,
- process nutrients, hormones, and medications,
- produce the proteins responsible for blood clotting,
- produce bile, which helps the body absorb fats, including cholesterol, and fat-soluble vitamins (A, D, E, and K).
A healthy liver is essential for survival, and under normal circumstances it is capable of regenerating most of its own cells when they become damaged. In cirrhosis, however, this regenerative capacity is progressively lost.
Alcohol use, together with viral hepatitis, is responsible for the majority of cirrhosis cases worldwide (liver cirrhosis accounts for approximately 15% of all alcohol-related deaths globally).
In the early stages, symptoms of cirrhosis are typically absent or minimal, which unfortunately often leads to delayed diagnosis. Over time, as the liver progressively loses its ability to function properly, symptoms begin to appear, including:
- loss of appetite,
- nausea,
- itching.
In later stages, symptoms often expand to include:
- jaundice,
- vomiting blood,
- dark, tarry-looking stools,
- fluid accumulation in the legs (edema) and abdomen (ascites).
Causes
Liver cirrhosis has many possible causes, but in industrialized countries, alcohol consumption and hepatitis C are by far the most common. Obesity (leading to metabolic dysfunction-associated steatotic liver disease, or MASLD) is also becoming an increasingly common cause of liver damage, either on its own or in combination with other risk factors.
Many people with cirrhosis have more than one contributing cause, but the condition never results from a single acute injury or short-term insult; it typically takes years of chronic damage for cirrhosis to develop.
Among the most significant causes are:
-
Alcohol-related liver disease. Most people who drink alcohol do not develop liver damage, but prolonged consumption over many years can cause chronic injury. The amount of alcohol needed to damage the liver varies considerably from person to person. For women, drinking two to three glasses of wine or beer per day, and for men three to four drinks per day, can be enough to cause cirrhosis-related damage over the years. Historically, alcohol-related cases have caused more deaths than cirrhosis due to other causes, although deaths from obesity-related cirrhosis have recently been on the rise. In simplified terms, alcohol-related liver damage typically progresses from alcoholic hepatitis and/or fatty liver disease which, if not addressed through abstinence, can progress to liver fibrosis and eventually cirrhosis.
-
Chronic hepatitis C. The hepatitis C virus is a liver infection transmitted through contact with infected blood. Hepatitis C causes liver inflammation and damage over time, which can lead to cirrhosis.
-
Chronic hepatitis B and D. The hepatitis B virus causes a liver infection transmitted through contact with infected blood, semen, or other bodily fluids. Like hepatitis C, hepatitis B causes liver inflammation and can lead to cirrhosis. The hepatitis B vaccine is now routinely given to all infants and to many adults to prevent infection. Hepatitis D is another virus that infects the liver and can lead to cirrhosis, but it only occurs in people who already have hepatitis B.
-
Metabolic dysfunction-associated steatotic liver disease (MASLD). In this condition, fat accumulates in the liver to the point of causing cirrhosis. This increasingly common condition is associated with obesity, diabetes, protein malnutrition, coronary artery disease, and corticosteroid medications.
-
Autoimmune hepatitis. This form of hepatitis occurs when the immune system begins attacking liver cells, causing inflammation, liver damage, and eventually cirrhosis. Researchers believe genetic factors may make certain individuals more susceptible to autoimmune conditions. Approximately 70% of people with autoimmune hepatitis are female.
-
Diseases that damage or destroy the bile ducts. Numerous diseases can damage or destroy the ducts that carry bile (a substance involved in digestion) away from the liver, causing bile to back up into the liver until it eventually causes cirrhosis. In adults, the most common disease in this category is primary biliary cholangitis, a condition in which the bile ducts become inflamed, damaged, and eventually disappear. Secondary biliary cirrhosis can occur if the bile ducts are accidentally injured or improperly closed during gallbladder surgery. Primary sclerosing cholangitis is another condition that causes damage and scarring to the bile ducts. In infants, damaged bile ducts are commonly caused by Alagille syndrome or biliary atresia, a condition in which the ducts are absent or damaged.
-
Inherited diseases. Cystic fibrosis, alpha-1 antitrypsin deficiency, hemochromatosis, Wilson’s disease, galactosemia, and glycogen storage diseases are all inherited conditions that interfere with the liver’s ability to function and process enzymes, proteins, metals, and other substances the body needs to work properly. Cirrhosis can develop as a result of these conditions.
-
Medications, toxins, and infections. Other causes of cirrhosis include medication overuse, prolonged exposure to toxic chemicals, parasitic infections, and repeated episodes of heart failure leading to liver congestion.
Symptoms
Many people with cirrhosis experience no symptoms at all in the early stages of the disease. However, as the condition inevitably progresses, symptoms may begin to appear, including:
- weakness and fatigue,
- loss of appetite,
- nausea,
- weight loss.
In more advanced stages, patients may develop:
- abdominal pain and bloating, when fluid begins to accumulate in the abdomen (see the “Risks” section),
- stomach pain,
- fever and chills,
- vomiting (sometimes containing blood),
- dark urine and tarry-looking stools,
- diarrhea,
- itching,
- jaundice,
- spider angiomas (visible small blood vessels on the skin),
- leg swelling due to fluid retention,
- menstrual cycle changes in women.
When the brain becomes affected (a condition known as hepatic encephalopathy), symptoms may also include:
- personality changes,
- confusion,
- difficulty concentrating,
- memory loss,
- hallucinations.
Risks and Survival
Cirrhosis is associated with a 10-year mortality rate ranging between approximately 34% and 66%, depending heavily on the underlying cause. Alcohol-related cirrhosis often carries a more complex prognosis if drinking is not stopped early, while newer therapies for viral hepatitis have significantly improved life expectancy for affected patients.
As cirrhosis and liver function progressively worsen, one or more complications may develop; in some patients, these complications may even represent the first noticeable signs of the disease.
-
Edema and ascites. As liver damage progresses to an advanced stage, fluid begins to accumulate in the legs (edema) and abdomen (ascites). Ascites can lead to bacterial peritonitis, a serious and potentially life-threatening infection.
-
Bruising and bleeding. When the liver slows or stops producing the proteins needed for blood clotting, bruising or easy bleeding (such as nosebleeds and bleeding gums) can develop.
-
Portal hypertension. Normally, blood from the intestines and spleen is carried to the liver through the portal vein. Cirrhosis slows normal blood flow, which increases pressure within the portal vein, a condition known as portal hypertension.
-
Esophageal varices and gastropathy. When portal hypertension develops, blood vessels in the esophagus (varices) or stomach (gastropathy) can become enlarged, sometimes both at once. These enlarged blood vessels are more likely to rupture due to thinning of their walls combined with increased pressure. If they burst, severe bleeding can occur in the upper stomach or esophagus, requiring immediate medical attention.
-
Splenomegaly (enlarged spleen). When portal hypertension develops, the spleen tends to enlarge and trap white blood cells and platelets, reducing their numbers in the bloodstream. A low platelet count can be one of the earliest indicators that cirrhosis is developing.
-
Jaundice. Jaundice occurs when the diseased liver is no longer able to remove bilirubin from the blood, causing yellowing of the skin and the whites of the eyes.
-
Gallstones. If cirrhosis prevents bile from flowing freely to and from the gallbladder, the bile can harden and form gallstones.
-
Drug sensitivity. Cirrhosis slows the liver’s ability to filter medications out of the bloodstream. When this happens, medications remain active in the body longer than expected and can accumulate to potentially dangerous levels.
-
Hepatic encephalopathy. A poorly functioning liver is unable to remove toxins from the blood, and these toxins eventually accumulate in the brain. This buildup can impair mental function and, in severe cases, lead to coma.
-
Insulin resistance and type 2 diabetes. Cirrhosis causes insulin resistance, which can lead to the development of diabetes.
-
Liver cancer. Hepatocellular carcinoma is a type of liver cancer that can develop in people with cirrhosis.
-
Other complications. Cirrhosis can cause immune system dysfunction, leading to an increased risk of infection. It can also cause kidney and lung failure in severe cases.
Diagnosis
The diagnostic approach to cirrhosis has evolved significantly, with modern medicine now favoring non-invasive methods that can identify the disease even in its earliest stages (compensated cirrhosis). The primary goal is to assess the degree of liver fibrosis (scarring) and monitor for signs of portal hypertension.
Clinical Evaluation and Non-Invasive Testing
Diagnosis begins with a thorough medical history to identify risk factors (alcohol use, metabolic syndrome, viral exposure) along with a physical examination. However, since cirrhosis is often silent in its early stages, confirmation requires objective testing tools:
-
Serum biomarkers: In addition to standard laboratory tests such as bilirubin, INR, albumin, and liver enzymes, calculated scores such as the FIB-4 index or the ELF score are used. These tests combine multiple blood values to estimate the severity of fibrosis without requiring a needle biopsy.
-
Liver elastography (FibroScan): This is today’s non-invasive gold standard. Similar to an ultrasound, it measures liver “stiffness” using shear-wave technology. The stiffer the liver tissue, the greater the degree of fibrosis. This test is essential both for early diagnosis and for monitoring treatment effectiveness over time.
-
Advanced imaging: Abdominal ultrasound is the first-line imaging test used to visualize liver structure (irregular margins, enlarged spleen) and detect ascites. CT scans and MRI are reserved for characterizing suspicious nodules that may indicate liver cancer.
Endoscopy and Biopsy
Upper endoscopy (gastroscopy) is an essential diagnostic step in patients with suspected cirrhosis, used to detect esophageal varices early, a sign of advanced portal hypertension. Liver biopsy, once considered indispensable, is now performed only rarely, typically when non-invasive test results are inconsistent or when the exact cause of the disease needs further clarification (for example, in rare diseases or suspected overlapping autoimmune conditions).
Staging and Prognosis
Two main scoring systems are used to determine disease severity and guide treatment decisions, including eligibility for the liver transplant waiting list:
-
Child-Pugh score: Assesses liver synthetic function based on clinical parameters (ascites, encephalopathy) combined with biochemical test results.
-
MELD score: A numerical score based on creatinine, bilirubin, and INR levels. This score is essential for establishing priority on liver transplant waiting lists, since it reflects the short-term risk of serious complications.
Treatment and Care
The primary goal of cirrhosis treatment is to halt the progression of liver damage and prevent life-threatening complications. Treatment strategies today are personalized based on the underlying cause and the stage of the disease.
Treating the Underlying Cause (Etiological Therapy)
Removing the initial cause of liver injury can, in some cases, lead to partial regression of fibrosis:
-
Viral hepatitis: Direct-acting antiviral (DAA) medications can now eradicate hepatitis C in nearly 100% of cases. For hepatitis B, long-term suppressive therapies dramatically reduce liver inflammation.
-
Alcohol-related cirrhosis: Complete abstinence from alcohol is the only intervention capable of significantly improving survival. Psychological or pharmacological support programs may be necessary to achieve this.
-
MASLD/metabolic cirrhosis: Strict management of diabetes, high blood pressure, and obesity through diet and physical activity is essential to halt further liver damage.
-
Autoimmune and biliary diseases: Corticosteroids, immunosuppressants, or specific bile acid medications are used to reduce immune system activity or improve bile flow, depending on the underlying condition.
Managing Complications
In advanced stages, treatment focuses on managing symptoms and preventing medical emergencies:
-
Portal hypertension and varices: Beta-blocker medications (such as carvedilol) are used to reduce venous pressure and prevent bleeding episodes. In cases of acute bleeding, endoscopic band ligation of the varices is performed.
-
Ascites and edema: The cornerstone of treatment is dietary sodium restriction combined with diuretic medications. When fluid accumulation is significant, paracentesis (needle drainage) may be performed.
-
Hepatic encephalopathy: Treatment focuses on reducing the absorption of intestinal toxins (particularly ammonia) through the use of osmotic laxatives such as lactulose, along with non-absorbable antibiotics.
Nutrition and Lifestyle
Nutritional management is an integral part of cirrhosis treatment, since malnutrition and muscle mass loss (sarcopenia) can significantly worsen prognosis:
-
Diet: Should be high in calories with a normal (not restricted) protein intake. Contrary to older recommendations, severe protein restriction is no longer advised, except in specific cases of acute encephalopathy.
-
The “bedtime snack” strategy: A well-established clinical recommendation is consuming a small, late-evening snack rich in complex carbohydrates before bed, in order to prevent the body from breaking down its own muscle protein during the overnight fasting period.
-
Physical activity: Light, consistent exercise helps preserve muscle mass and supports healthy metabolic function.
Liver Transplant
When cirrhosis becomes decompensated and medical therapies are no longer sufficient to control the disease, liver transplantation becomes the only definitive treatment option. Patient selection is carried out by multidisciplinary committees that assess urgency (using the MELD score) along with the candidate’s overall physical and psychological suitability for transplant. Modern surgical techniques and improved anti-rejection protocols now allow for excellent long-term survival rates following transplantation.
Supportive Approaches and Integrative Medicine
While these approaches cannot replace medical treatment, certain complementary practices may help improve quality of life:
-
Milk thistle: Contains silymarin, which has shown antioxidant properties in some research settings, but should only be used under strict medical supervision due to the risk of drug interactions.
-
Itch management: Persistent itching may require specific medications that work by binding bile salts or by modulating nerve receptor activity.
Prevention
While cirrhosis cannot always be prevented, you can significantly reduce your risk by taking care of your liver:
-
Drink alcohol in moderation, or avoid it entirely. Current public health guidelines suggest there is no truly “safe” level of alcohol consumption when it comes to liver health.
-
Follow a healthy diet. Choose a diet rich in fruits and vegetables, favor whole grains, and reduce your intake of ultra-processed foods.
-
Maintain a healthy body weight. Fat accumulation in the liver is one of the leading emerging causes of cirrhosis worldwide.
-
Use household chemicals carefully and sparingly, always following proper safety precautions.
-
Reduce your risk of hepatitis. Never share needles, and use condoms during casual sexual encounters.
Talk to your doctor about whether vaccination against hepatitis B and hepatitis A may be right for you.
Frequently Asked Questions
What is liver cirrhosis?
Liver cirrhosis is irreversible liver damage that causes a progressive loss of liver function over time.
What are the symptoms?
In the early stages, cirrhosis may cause no noticeable symptoms at all. As liver damage progresses, symptoms may begin to appear, including:
- fatigue and weakness
- nausea
- loss of appetite
In more advanced stages, patients may develop:
- abdominal and leg swelling
- easy bleeding and bruising
- jaundice (yellowing of the skin and eyes)
- dark urine and tarry stools
What causes death in liver cirrhosis?
The most common cause of death is liver failure (when the liver stops functioning entirely). Other common causes include gastrointestinal bleeding and liver cancer.
How is cirrhosis treated?
Unfortunately, cirrhosis is an irreversible condition, but through appropriate medications and lifestyle changes, it is possible to slow its progression and effectively manage its main symptoms and complications.
What is the life expectancy with cirrhosis?
Life expectancy is closely tied to the stage of the disease and the presence of complications. Because of this, the range of outcomes is quite broad, spanning anywhere from 1 to 20 years or more, depending on individual circumstances.
Sources and Bibliography
- NIH - National Institute of Diabetes and Digestive and Kidney Diseases
- NHS - Cirrhosis Overview
- AISF (Italian Association for the Study of the Liver) - Clinical Guidelines
- Mayo Clinic - Cirrhosis
- American Liver Foundation
